| Views | |
|---|---|
| TFE3 activation in a TSC1‐altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms | 182 |
| July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | |
|---|---|---|---|---|---|---|---|
| TFE3 activation in a TSC1‐altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms | 8 | 4 | 13 | 27 | 7 | 3 | 1 |
| Views | |
|---|---|
| 2020_Schmiester_etal.pdf | 134 |
